Melendez-Torres, G. J.Auguste, PeterArmoiry, XavierMaheswaran, HendramoorthyCourt, RachelMadan, JasonKan, AlanLin, StephanieCounsell, CarlPatterson, JacobyRodrigues, JeremyCiccarelli, OlgaFraser, HannahClarke, Aileen2017-09-282017-09-282017-09-01Melendez-Torres, G J, Auguste, P, Armoiry, X, Maheswaran, H, Court, R, Madan, J, Kan, A, Lin, S, Counsell, C, Patterson, J, Rodrigues, J, Ciccarelli, O, Fraser, H & Clarke, A 2017, 'Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis : systematic review and economic evaluation', Health Technology Assessment, vol. 21, no. 52, pp. 1-352. https://doi.org/10.3310/hta215201366-5278ORCID: /0000-0001-6622-7839/work/164505733http://hdl.handle.net/2164/9366The authors gratefully acknowledge the assistance of Ms Karoline Munro and Dr Martin Connock. The authors also acknowledge the work and assistance of Charles Dobson and the RSS Steering Group.3522986280engR Medicine (General)National Institute for Health Research (NIHR)R1Journal article10.3310/hta215202152